Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Eritromicina

Lauromicina, Zynerit e altri

Bibliografia - Quali fonti bibliografiche per Eritromicina?

1. Abouesh A. et al., J. Clin. Psychopharmacol., 2002, 22 (1), 71.

2. AIFA, Agenzia Italiana del Farmaco, Farmaci e gravidanza, 2005, Ministero della Salute.

3. Aranko K. et al., Br. J. Clin. Pharmacol., 1994, 38, 363.

4. Ayanian J.Z. et al., Ann. Intern. Med., 1988, 109, 682.

5. Bachman K. et al., Res. Comm. Pathol. Pharmacol., 1984, 46, 207.

6. Balows A., Fraser D., Ann. Intern. Med., 1979, 90, 489.

7. Bartkowski R.R. et al., Clin. Pharmacol. Ther., 1989, 46, 99.

8. Berger T.M. et al., Pediatrics, 1992, 90, 624.

9. Burstein G.R., Clin. Infect. Dis., 1999, 28 Suppl. 1/S66.

10. Caracao Y. et al., J. Rheumatol., 1992, 19, 494.

11. Cohen L.G. et al., Arch. Intern. Med., 1996, 156, 657.

12. Cooper W.O. et al., Obstet. Gynecol., 2002, 100 (1), 101.

13. Cooper W.O et al., Arch. Pediatr. Adolesc. Med., 2002a, 156 (7), 647.

14. Czeizel A.E. et al., Reprod. Toxicol., 1999, 13 (6), 531.

15. Eady E.A. et al., Br. J. Dermatol., 1996, 134, 107.

16. Ellsworth A.J. et al., J. Fam. Pract., 1990, 31, 265.

17. Florido Lopez J.F. et al., Allergy, 1991, 46 (1), 77.

18. Francis H. et al., Clin. Rheumatol., 1984, 3, 243.

19. Friedman H.S., Chest 1982, 82, 202.

20. Gantz N.M. et al., Ann. Intern. Med., 1977, 88, 866.

21. Godin J.R.P. et al., Drug Intell. Clin. Pharm., 1986, 20, 485.

22. Goldschmidt N. et al., Ann. Pharmacother., 2001, 35, 1396.

23. Gouyon J.B. et al., Pediatr. Infect. Dis. J., 1994, 13, 840.

24. Gupta S.K. et al., Br. J. Clin. Pharmacol., 1989, 27, 475.

25. Hassel et al., Ann. Intern. Med., 1991, 115, 69.

26. Hildebrandt R. et al., Eur.J.Clin. Pharmacol, 1984, 26, 485.

27. Hiller A. et al., Br. J. Anaesth., 1990, 65, 826.

28. Iliopoulou A. et al., Br. J. Clin. Pharmacol., 1982, 14, 495.

29. Jensen C. et al., Lancet, 1994, 344, 825.

30. Kallen B.A. et al., Reprod. Toxicol., 2005, 20 (2), 209.

31. Kantola T. et al., Clin. Pharmacol. Ther., 1998, 64, 177.

32. Kataoka M. et al., Eur. J. Pharm. Sci., 2011, disponibile online 22 settembre.

33. Kenyon S. et al., Lancet, 2008, 372 (9646), 1310.

34. Kenyon S. et al., lancet, 2008a, 372 )9646), 1310.

35. Kivisto K.T. et al., Clin. Pharmacol. Ther., 1997, 62, 348.

36. La Force C.F. et al., J. Clin. Immunol., 1983, 72, 34.

37. Lestico M.R., Smith A.D., Am. Health-Syst. Pharm., 1995, 52, 1805.

38. Lindebaum J. et al., NEJM, 1981, 305, 789.

39. Mahon B.E. et al., J. Pediatr., 2002, 139 (3), 380.

40. Martindale, The complete drug reference, ed 32, 1999, Pharmaceutical Press.

41. Matsuda S., Biol. Res. Pregnancy Perinatol., 1984, 5, 57.

42. Mogford N. et al., BMJ, 1994, 309, 1620.

43. Moore MR, Porphyria: drug lists, 1991.

44. Moore T.J. et al., Pediatrics, 2002, 110, e53.

45. Muck W. et al., Eur. J. Clin. Pharmacol., 1998, 53, 469.

46. Muirhead G.J. et al., Br. J. Clin. Pharmacol., 2002, 53 Suppl. 1, 37S.

47. Nattel S. et al., Am. J. Med., 1990, 89, 235.

48. Navarro J.A. et al., Allerg. Clin. Immunol. Intern., 2000, Suppl. 2, 158

49. Nelson M.V. et al., Clin. Pharmacol. Ther., 1990, 47, 166.

50. Noel G.J. et al., J. Clin. Pharmacol., 2004, 44, 464.

51. Packman A.M. et al., Int. J. Dermatol., 1996, 35, 209.

52. Petri M., Allbriton J., J. Rheumatol., 1992, 19 (2), 265.

53. Phillips J.P; et al., J. Clin. Psychopharmacol., 1986, 6, 297.

54. Ragosta M. et al., Am. J. Med., 1989, 86, 465.

55. Ray W.A. et al., NEJM, 2004, 351, 1089.

56. Redington K. et al., Ann. Intern. Med., 1992, 116, 877.

57. Sanfilippo J.A., J. Ped. Sur., 1976, 11, 177.

58. Scchoenerberg R.A. et al., BMJ, 1990, 300, 1375.

59. Schlienger R.G. et al., 2001, 161 (16), 2021.

60. Schwartz J. et al., South Med. J., 1983, 76, 91.

61. Sheperd A.M. et al., Br. J. Clin. Phar,acol., 1977, 4, 315.

62. Siedlik P.H. et al., J. Clin. Pharmacol., 1999, 39, 501.

63. Spach D.H. et al., West J. Med., 1991, 154, 213.

64. Spinler S.A. et al., Clin. Pharmacol. Ther., 1995, 57, 89.

65. Sorensen H.T. et al., Scand. J. Infect. Dis., 2003, 35 (2), 104.

66. Stafstrom C.E. et al., Arch. Pediatr. Adolesc. Med., 1995, 149, 99.

67. Stainforth J. et al., J. Dermatol. Treat., 1993, 4, 119.

68. Tashida S.J. et al., Pharmacotherapy, 1996, 16, 663.

69. Tenenbein M.S., Tenenbein M., Pediatr. Emerg. Care, 2005, 21 (10), 675.

70. Tobe S.W. et al., Cancer Chemother. Pharmacol., 1995, 35, 188.

71. Yasui N. et al., Clin. Pharmacol. Ther., 1996, 59, 514.

72. Wong Y.Y. et al., Clin. Pharmacol. Ther., 1983, 33, 460.

73. Wright A.J. et al., CMAJ, 2011, 183, 303.

74. Wroblewski B.A. et al., JAMA, 1986, 255, 1165.

75. Zhang Y. et al., Zhonghua Fu Chan Ke Za Zhi. 1997, 32, 288.